EUVIMEDExplore EUVIMED
Übersichtsarbeit

Inhibitors of PIM‐1 Signaling Pathways as Anticancer Agents: Pharmacological and Structural Viewpoints

Banty Kumar, Ankur Vaidya iD, Shweta Jain iD, Sanjeev Kumar Sahu iD, Preeti Patel iD, Vivek Asati iD

ChemMedChem · 2026-10-28 · 21 (20)

DOI: 10.1002/cmdc.70533 ↗

At a glance

Übersichtsarbeit in ChemMedChem, published online on 2026-10-14. Written by Banty Kumar and 5 co-authors. Institution: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Uttar Pradesh University of Medical Sciences, Etawah, U.P., India. Major MEDLINE topics: Proto-Oncogene Proteins c-pim-1, Antineoplastic Agents, Signal Transduction, Protein Kinase Inhibitors. 101 references.

AbstractSubjectsBibliographic detailsCiteRelated studies

Abstract (original language)

Pim‐1, a carcinogenic threonine and serine kinase, inhibits apoptosis and advances the cell cycle. It is overexpressed in several human cancers. The proviral integration site of Moloney murine leukemia virus 1 is Pim‐1. Previous studies have shown that the Pim‐1 30‐UTR regulates the stability of Pim‐1 mRNA. Threonine and serine are identified as the proto‐oncogene Pim‐1 kinase. Pim‐1 mediates numerous biological processes, including apoptosis, cell division, proliferation, and cancer. Pim‐1‐mediated anticancer activity has been reported in several analogs of thiazole/ bis ‐thiazole, tetrazine, thiophenes, quinoline, pyrazolopyrimidine, 3‐cyanopyridine, thiazolidine‐2,4‐dione, thieno[2,3‐ b ]pyridine, triazolo[4,3‐ b ]pyridazine, pyrazolo[1,5‐ a ]pyrimidines, and pyrazolo[3,4‐ b ]pyridine derivatives. Additionally, flavonoids and amino alcohol compounds that constitute Pim‐1‐mediated cancer therapy have also been identified thus far. Many compounds with Pim‐1‐mediated cytotoxicity have been discovered up to this point, and scientists are currently concentrating on bringing novel compounds with anticancer potential to the market.

Subjects

MeSH terms (MEDLINE)

Proto-Oncogene Proteins c-pim-1Antineoplastic AgentsSignal TransductionProtein Kinase InhibitorsNeoplasmsHumansProto-Oncogene MasAnimalsApoptosisStructure-Activity Relationship

Author keywords

Pim‐1amino alcoholapoptosiscancerflavonoidquinoline

Substances

Proto-Oncogene Proteins c-pim-1Antineoplastic AgentsProto-Oncogene MasMAS1 protein, humanProtein Kinase Inhibitors

Authors and institutions

  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Uttar Pradesh University of Medical Sciences, Etawah, U.P., India.
  • Sir Madanlal Institute of Pharmacy, Etawah, U.P., India.
  • School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar, Punjab, India.
  • Department of Pharmaceutical Chemistry and Analysis, ISF College of Pharmacy, Moga, Punjab, India.

ORCID profiles: Ankur Vaidya, Shweta Jain, Sanjeev Kumar Sahu, Preeti Patel, Vivek Asati

Cite

APA

Kumar, B., Vaidya, A., Jain, S., Sahu, S. K., Patel, P., & Asati, V. (2026). Inhibitors of PIM‐1 Signaling Pathways as Anticancer Agents: Pharmacological and Structural Viewpoints. ChemMedChem, 21(20). https://doi.org/10.1002/cmdc.70533

Vancouver

Kumar B, Vaidya A, Jain S, Sahu SK, Patel P, Asati V. Inhibitors of PIM‐1 Signaling Pathways as Anticancer Agents: Pharmacological and Structural Viewpoints. ChemMedChem. 2026;21(20). doi:10.1002/cmdc.70533

BibTeX
@article{Kumar2026,
  author = {Kumar, Banty and Vaidya, Ankur and Jain, Shweta and Sahu, Sanjeev Kumar and Patel, Preeti and Asati, Vivek},
  title = {Inhibitors of PIM‐1 Signaling Pathways as Anticancer Agents: Pharmacological and Structural Viewpoints},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {20},
  doi = {10.1002/cmdc.70533}
}
Start for free →